ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Nupharma Limited

Nupharma Limited is a dormant company incorporated on 9 May 2011 with the registered office located in Edgware, Greater London. Nupharma Limited was registered 14 years ago.
Status
Dormant
Dormant since 6 years ago
Company No
07625707
Private limited company
Age
14 years
Incorporated 9 May 2011
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 7 September 2025 (1 month ago)
Next confirmation dated 7 September 2026
Due by 21 September 2026 (10 months remaining)
Last change occurred 4 years ago
Accounts
Submitted
For period 1 Oct30 Sep 2024 (1 year)
Accounts type is Dormant
Next accounts for period 30 September 2025
Due by 30 June 2026 (8 months remaining)
Address
SEAFIELDS CHARTERED ACCOUNTANTS
50 Bullescroft Road
Edgware
Middlesex
HA8 8RW
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
4
Controllers (PSC)
1
Director • Pharmacist • British • Lives in England • Born in Dec 1956
Director • Pharmacist • British • Lives in England • Born in Oct 1954
Director • Management Consultant • British • Lives in UK • Born in Feb 1953
Mr Vishrut Ramanbhai Patel
PSC • British • Lives in England • Born in Dec 1956
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Glosgrange Limited
Pareshkumar Induprasad Patel is a mutual person.
Active
Sunlodge Properties Limited
Pareshkumar Induprasad Patel is a mutual person.
Active
Geewick Limited
Vishrut Ramanbhai Patel and Pareshkumar Induprasad Patel are mutual people.
Active
Macol Limited
Vishrut Ramanbhai Patel is a mutual person.
Active
Silent Bob Ltd
Pareshkumar Induprasad Patel is a mutual person.
Active
Laboratories Biophysics Limited
Vishrut Ramanbhai Patel is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Sep 2024
For period 30 Sep30 Sep 2024
Traded for 12 months
Cash in Bank
£7.25K
Decreased by £43.31K (-86%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£2.96M
Decreased by £43.31K (-1%)
Total Liabilities
-£2.96M
Decreased by £43.31K (-1%)
Net Assets
£300
Same as previous period
Debt Ratio (%)
100%
Decreased by 0% (-0%)
Latest Activity
Confirmation Submitted
1 Month Ago on 17 Sep 2025
Dormant Accounts Submitted
6 Months Ago on 24 Apr 2025
Confirmation Submitted
1 Year 1 Month Ago on 21 Sep 2024
Dormant Accounts Submitted
1 Year 5 Months Ago on 7 May 2024
Charge Satisfied
1 Year 7 Months Ago on 18 Mar 2024
Confirmation Submitted
2 Years 1 Month Ago on 13 Sep 2023
Dormant Accounts Submitted
2 Years 4 Months Ago on 9 Jun 2023
Confirmation Submitted
3 Years Ago on 8 Sep 2022
Dormant Accounts Submitted
3 Years Ago on 24 May 2022
Mr Paresh Kumar Induprasad Patel Appointed
4 Years Ago on 30 Sep 2021
Get Credit Report
Discover Nupharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 7 September 2025 with no updates
Submitted on 17 Sep 2025
Accounts for a dormant company made up to 30 September 2024
Submitted on 24 Apr 2025
Confirmation statement made on 7 September 2024 with no updates
Submitted on 21 Sep 2024
Accounts for a dormant company made up to 30 September 2023
Submitted on 7 May 2024
Satisfaction of charge 1 in full
Submitted on 18 Mar 2024
Confirmation statement made on 7 September 2023 with no updates
Submitted on 13 Sep 2023
Accounts for a dormant company made up to 30 September 2022
Submitted on 9 Jun 2023
Confirmation statement made on 7 September 2022 with no updates
Submitted on 8 Sep 2022
Accounts for a dormant company made up to 30 September 2021
Submitted on 24 May 2022
Appointment of Mr Paresh Kumar Induprasad Patel as a director on 30 September 2021
Submitted on 1 Oct 2021
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year